Early effects of lipopolysaccharide-induced inflammation on foetal brain development in rat von Ghiani, Cristina A, Mattan, Natalia S, Nobuta, Hiroko, Malvar, Jemily S, Boles, Julie, Ross, Michael G, Waschek, James A, Carpenter, Ellen M, Fisher, Robin S, de Vellis, Jean

Volltext

Genetic program of neuronal differentiation and growth induced by specific activation of NMDA receptors von Ghiani, Cristina A, Beltran-Parrazal, Luis, Sforza, Daniel M, Malvar, Jemily S, Seksenyan, Akop, Cole, Ruth, Smith, Desmond J, Charles, Andrew, Ferchmin, Pedro A, de Vellis, Jean

Volltext

Correlation of Clinical and Dosimetric Factors With Adverse Pulmonary Outcomes in Children After Lung Irradiation von Venkatramani, Rajkumar, MD, MS, Kamath, Sunil, MD, Wong, Kenneth, MD, Olch, Arthur J., PhD, Malvar, Jemily, MS, Sposto, Richard, PhD, Goodarzian, Fariba, MD, Freyer, David R., DO, MS, Keens, Thomas G., MD, Mascarenhas, Leo, MD, MS

Volltext

Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells von Borriello, Lucia, Nakata, Rie, Sheard, Michael A, Fernandez, G Esteban, Sposto, Richard, Malvar, Jemily, Blavier, Laurence, Shimada, Hiroyuki, Asgharzadeh, Shahab, Seeger, Robert C, DeClerck, Yves A

Volltext

TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells von Tran, Hung C, Wan, Zesheng, Sheard, Michael A, Sun, Jianping, Jackson, Jeremy R, Malvar, Jemily, Xu, Yibing, Wang, Larry, Sposto, Richard, Kim, Eugene S, Asgharzadeh, Shahab, Seeger, Robert C

Volltext

Impact on Survival and Toxicity by Duration of Weight Extremes During Treatment for Pediatric Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group von ORGEL, Etan, SPOSTO, Richard, MALVAR, Jemily, SEIBEL, Nita L, LADAS, Elena, GAYNON, Paul S, FREYER, David R

Volltext

Case‐linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute‐Designated comprehensive cancer center von Collins, Chelsea L., Malvar, Jemily, Hamilton, Ann S., Deapen, Dennis M., Freyer, David R.

Volltext

LGG-23. Cardiac function in children and young adults treated with MEK inhibitors: a single institution retrospecive cohort study von Robison, Nathan, Su, Jennifer, Fang, Melody, Malvar, Jemily, Menteer, Jondavid

Volltext

CHIEF: A retrospective self‐control study of children with severe hemophilia A without inhibitors comparing emicizumab to FVIII prophylaxis von Mashiach, Daniel, Mead, Patrice, Carneiro, Kendall, Malvar, Jemily, Knight, Susan, Young, Guy

Volltext

Is ≥ 100% the magic number to rule out the laboratory diagnosis of von W illebrand disease based on initial testing? von Weyand, Angela C., Kouides, Peter, Malvar, Jemily, Jaffray, Julie

Volltext

Determining the approximate factor VIII level of patients with severe haemophilia A on emicizumab using in vivo global haemostasis assays von Kizilocak, Hande, Marquez‐Casas, Elizabeth, Malvar, Jemily, Carmona, Roxana, Young, Guy

Volltext

Safety of FEIBA and emicizumab (SAFE): Dose escalation study evaluating the safety of in vivo administration of activated prothrombin complex concentrate in haemophilia A patients... von Kizilocak, Hande, Marquez‐Casas, Elizabeth, Malvar, Jemily, Young, Guy

Volltext

OTHR-09. A RETROSPECTIVE COHORT STUDY EXAMINING RADIOLOGIC AND CLINICAL CHARACTERISTICS OF CHILDREN AND ADOLESCENTS WITH ATYPICAL/COMPLEX PINEAL CYSTS von Tahbaz, Meghan, Malvar, Jemily, Khan, Sara, Tamrazi, Benita, Chi, Yueh-Yun, Robison, Nathan

Volltext

COVID-19 in Children, Adolescents and Young Adults with Hematological Malignancies von Parker, Rebecca S, Malvar, Jemily, Doan, Andrew, Aguayo-Hiraldo, Paibel, Parekh, Chintan

Volltext

Factor VIII Level Comparison in Patients with Severe Hemophilia a on Emicizumab with Inhibitors with One Stage, Bovine and Human Chromogenic Assays and the Factor VIII Equivalency... von Kizilocak, Hande, Marquez-Casas, Elizabeth, Brown, Joshua, Malvar, Jemily, Young, Guy

Volltext

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia... von Tasian, Sarah K, Silverman, Lewis B, Whitlock, James A, Sposto, Richard, Loftus, Joseph P, Schafer, Eric S, Schultz, Kirk R, Hutchinson, Raymond J, Gaynon, Paul S, Orgel, Etan, Bateman, Caroline M, Cooper, Todd M, Laetsch, Theodore W, Sulis, Maria Luisa, Chi, Yueh-Yun, Malvar, Jemily, Wayne, Alan S, Rheingold, Susan R

Volltext

Factor VIII Level Comparison in Patients with Severe Hemophilia a on Emicizumab with Inhibitors with One Stage, Bovine and Human Chromogenic Assays and the Factor VIII Equivalency... von Kizilocak, Hande, Marquez-Casas, Elizabeth, Brown, Joshua, Malvar, Jemily, Young, Guy

Volltext

Is ≥ 100% the magic number to rule out the laboratory diagnosis of von Willebrand disease based on initial testing? von Weyand, Angela C., Kouides, Peter, Malvar, Jemily, Jaffray, Julie

Volltext

Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study von Oberley, Matthew J., Raikar, Sunil S., Wertheim, Gerald B., Malvar, Jemily, Sposto, Richard, Rabin, Karen R., Punia, Jyotinder N., Seif, Alix E., Cahen, Viviane C., Schore, Reuven J., Luca, Dragos C., Guinipero, Terri, Woods, William G., O’Gorman, Maurice R. G., Orgel, Etan

Volltext

Comparison of bypassing agents in patients on emicizumab using global hemostasis assays von Kizilocak, Hande, Marquez‐Casas, Elizabeth, Phei Wee, Choo, Malvar, Jemily, Carmona, Roxana, Young, Guy

Volltext